Literature DB >> 7067218

A bovine low molecular weight bone morphogenetic protein (BMP) fraction.

M R Urist, A Lietze, H Mizutani, K Takagi, J T Triffitt, J Amstutz, R DeLange, J Termine, G A Finerman.   

Abstract

A low MW bone morphogenetic protein fraction (BMP) is quantitatively extracted from bovine bone matrix by an inorganic-organic CaCl2-urea solvent mixture and fractionated by ion exchange and gel chromatography. The BMP fraction induces differentiation of perivascular mesenchymal type cells into cartilage and bone inside the mouse's thigh, outside of double walled diffusion chamber, in muscle pouches in the rabbit anterior abdominal wall, and in 0.8 cm trephine defects in the rat's skull. Bovine BMP may consist of electrophoretic components ranging from 12 K to 30 K in MW. The main components correspond to a MW of 23 K, 18 K and 12 K when they are compared with the mobilities of standard proteins. Because it was invariably present in all of the fractions with osteoinductive activity, circumstantial evidence leads to a 17 to 18 K component for a BMP. The possibility of a diameter monomer system for BMP activity also warrants consideration. The polypeptide portion constitutes only about 80% to 85% of the dry weight of the mixture of the three electrophoretic components, and suggests that the BMP fraction contains glycoproteins. Characteristically, glycoproteins migrate anomalously on SDS gels and create doubt about whether the major bands represent true MW. Nevertheless, the data clearly point to the low MW protein fractions for the direction of future work on BMP.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7067218

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  11 in total

1.  50 years ago in CORR: Physiologic basis of bone-graft surgery Marshall R. Urist MD CORR 1953;1:207-216.

Authors:  Richard A Brand
Journal:  Clin Orthop Relat Res       Date:  2008-06-03       Impact factor: 4.176

2.  Purification and characterization of other distinct bone-inducing factors.

Authors:  E A Wang; V Rosen; P Cordes; R M Hewick; M J Kriz; D P Luxenberg; B S Sibley; J M Wozney
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 3.  Regulation of hematopoiesis.

Authors:  J F Desforges
Journal:  West J Med       Date:  1984-07

4.  Bone-derived factors active on bone cells.

Authors:  S Mohan; T Linkhart; J Farley; D Baylink
Journal:  Calcif Tissue Int       Date:  1984       Impact factor: 4.333

5.  A comparative evaluation of decalcified freeze dried bone allograft, hydroxyapatite and their combination in osseous defects of the jaws.

Authors:  Sonal Mishra; R K Singh; Shadab Mohammad; R Pradhan; U S Pal
Journal:  J Maxillofac Oral Surg       Date:  2010-11-20

6.  Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography.

Authors:  M R Urist; Y K Huo; A G Brownell; W M Hohl; J Buyske; A Lietze; P Tempst; M Hunkapiller; R J DeLange
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

7.  The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects.

Authors:  K Takagi; M R Urist
Journal:  Ann Surg       Date:  1982-07       Impact factor: 12.969

Review 8.  Bone morphogenetic protein: a review.

Authors:  G Aldinger; G Herr; W Küsswetter; H J Reis; F W Thielemann; U Holz
Journal:  Int Orthop       Date:  1991       Impact factor: 3.075

9.  In vitro induction of cartilage-specific macromolecules by a bone extract.

Authors:  S M Seyedin; A Y Thompson; D M Rosen; K A Piez
Journal:  J Cell Biol       Date:  1983-12       Impact factor: 10.539

10.  Control of the bone morphogenetic protein 7 gene in developmental and adult life.

Authors:  Leif Oxburgh
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.